Partnership for Glaucoma

NCT ID: NCT00672048

Last Updated: 2014-01-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

721 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-10-31

Study Completion Date

2013-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to develop new ways of assisting patients with glaucoma and their eye doctors in using the recommendations from practice guidelines.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Glaucoma is a leading cause of blindness and visual impairment in the United States, particularly among disadvantaged populations. Despite the presence of therapies proven in NEI, randomized controlled trials that can be delivered by more than 18,000 ophthalmologists and 34,000 optometrists, almost nothing is known about the content and quality of glaucoma care delivered by non-MD providers such as optometrists. With the numbers of people with glaucoma expected to more than double in the next twenty years in the face of no more than a 15% increase in the supply of eye care providers, methods to better support appropriate and high-quality care for chronic eye diseases such as glaucoma delivered by optometrists will become as critical, if not more so, as techniques to enhance quality care among ophthalmologists.

Our study is a community-based, randomized, controlled trial that evaluates the suitability and effectiveness of a technology-based (tablet computer) intervention within the context of a novel partnership between optometrists and patients with glaucoma to improve the process quality of care and ultimately outcomes of care. By using successfully implemented technology in novel applications,and by building on the success of ongoing community-based quality improvement projects in our region, the study provides a means for rapid translation into community care if the intervention is successful.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glaucoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Group Type OTHER

Computer Tablet

Intervention Type OTHER

A tablet computer based software application designed to collect structured clinical information from providers and patients at the point of care.

Continuing Education Course

Intervention Type OTHER

Annual standard continuing education

2

Control group to receive annual continuing education

Group Type OTHER

Continuing education

Intervention Type OTHER

Annual standard continuing education materials

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Computer Tablet

A tablet computer based software application designed to collect structured clinical information from providers and patients at the point of care.

Intervention Type OTHER

Continuing Education Course

Annual standard continuing education

Intervention Type OTHER

Continuing education

Annual standard continuing education materials

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

-Diagnosis of open angle glaucoma with documented visual field loss.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Alabama at Birmingham

OTHER

Sponsor Role collaborator

Duke University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paul Lee, MD, JD

Role: PRINCIPAL_INVESTIGATOR

Duke University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama

Birmingham, Alabama, United States

Site Status

Duke University

Durham, North Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Silvey GM, Lobach DF, Macri JM, Hunt M, Kacmaz RO, Lee PP. User interface considerations for collecting data at the point of care in the tablet PC computing environment. AMIA Annu Symp Proc. 2006;2006:1096.

Reference Type BACKGROUND
PMID: 17238715 (View on PubMed)

Silvey GM, Lobach DF, Macri JM, Hunt M, Kacmaz RO, Lee PP. Overcoming obstacles to collecting narrative data from eye care professionals at the point-of-care. AMIA Annu Symp Proc. 2005;2005:1116.

Reference Type BACKGROUND
PMID: 16779403 (View on PubMed)

Kacmaz RO, Arbanas JM, Lee PP, Lobach DF. Assessment of relative importance of tablet computer features in supporting direct electronic documentation of encounters by eye care professionals. AMIA Annu Symp Proc. 2005;2005:1001.

Reference Type BACKGROUND
PMID: 16779288 (View on PubMed)

Lobach DF, Silvey GM, Macri JM, Hunt M, Kacmaz RO, Lee PP. Identifying and overcoming obstacles to point-of-care data collection for eye care professionals. AMIA Annu Symp Proc. 2005;2005:465-9.

Reference Type BACKGROUND
PMID: 16779083 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01EY018405-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

Pro00002593

Identifier Type: -

Identifier Source: org_study_id

NCT01733498

Identifier Type: -

Identifier Source: nct_alias

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Glaucoma Exercise as Medicine Study (GEMS).
NCT05581498 NOT_YET_RECRUITING NA